Background {#Sec1}
==========

Non-tuberculous mycobacteria (NTM) include all *Mycobacterium* species other than *Mycobacterium tuberculosis* complex and *Mycobacterium leprae*. NTM are a group of over 150 enviromental species, but, due to recent advancement of molecular techniques, novel species are being identified \[[@CR1]\]. NTM are generally endowed with low pathogenicity to humans \[[@CR2]\], however some species are associated with a variety of human diseases, especially concomitantly to particular risk factors \[[@CR3]\]; respiratory tract infections are the most frequent, followed by lymphadenitis in children, disseminated infections in severely immunocompromised patients and skin infections \[[@CR4]\]. Although significant differences in geographic distribution of NTM have been observed \[[@CR5]\], species belonging to *Mycobacterium avium* complex (MAC), particularly *M. avium* and *M. intracellulare*, are the most frequently reported; other important human NTM pathogens include slowly growing mycobacteria, usually community-acquired from environmental or animal sources, such as *Mycobacterium kansasii*, *Mycobacterium xenopi*, *Mycobacterium malmoense,* and rapidly growing mycobacteria typically hospital-acquired, such as *Mycobacterium abscessus*, *Mycobacterium chelonae* and *Mycobacterium fortuitum*. A considerable increase in both incidence and prevalence of NTM infections has been observed worldwide in the past two decades, not only for the development of new and more sensitive molecular methods for NTM identification, but also for a real increase in NTM disease cases \[[@CR6]\]. Several European countries have published studies about NTM epidemiology showing an increase in NTM isolated from human clinical samples \[[@CR7]--[@CR9]\], however NTM epidemiology in Italy is largely unknown. The aim of the present survey is to provide an overview of the epidemiology and recent trend of NTM infections in a region of central Italy, Tuscany, over the last 11 years.

Methods {#Sec2}
=======

Clinical isolates {#Sec3}
-----------------

The survey include the complete collection of 147 NTM strains, isolated from the same number of patients, from a total of 42,055 clinical specimens at the Laboratory of Clinical Mycobacteriology of Pisa University Hospital, Italy, during an 11-year study period from 1 January 2004 to 31 December 2014. In the case of multiple consecutive positive cultures from the same patient, only the first isolate was included in the present study. All strains were isolated by using the BACTEC MGIT960 liquid culture system (Becton Dickinson, USA) and were identified by molecular probes (InnoLipa \[Innogenetics, Belgium\] and/or Genotype CM/AS \[Hain Lifescience, Germany\]) and by a multiplex PCR designed to discriminate MAC organisms \[[@CR10]\]. Patients' clinical information, including gender, age and site of infection, was obtained from clinical records; distinction between community-versus hospital-acquired infections was not possible.

Research ethics approval was not necessary for retrospective studies in our Institution; informed consent was not required as the data were analyzed anonymously.

Results and discussion {#Sec4}
======================

Between January 2004 and December 2014, a total of 42,055 clinical specimens collected from approximately 15,000 patients with suspected mycobacterial infection were tested; a total of 595 patients had cultures positive for mycobacteria; *M. tuberculosis* complex and NTM species were isolated from 448 (75.3 %) and 147 (24.7 %) patients, respectively. A total of 16 NTM species were isolated (Table [1](#Tab1){ref-type="table"}), the most common belonging to the MAC (*n* = 82, 55.8 %); in particular, *M. avium* subsp. *hominissuis* was detected in 61 (41.5 %) and *M. intracellulare* in 21 (14.3 %) patients. *M. gordonae* was the third prevalent species (*n* = 17, 11.6 %), followed by *M. xen*opi (*n* = 14, 9.5 %), *M. fortuitum* (*n* = 10, 6.8 %), and *M. kansasii* (*n* = 7, 4.8 %). In general, the species distribution of NTM isolated in our setting was close to that reported earlier in an inventory study of NTM in the European Union, which included Italy \[[@CR7]\]. Similarly to other studies \[[@CR9], [@CR11]\], the NTM infections were not associated with gender, although *M. intracellulare* and *M. kansasii* appeared to be more common in men (16 males *vs* 5 females, *P* = 0.002 for *M. intracellulare;* 6 males *vs* 1 females, *P* = 0.003 for *M. kansasii*, by χ2 analysis). In general, NTM isolates were largely prevalent in people older than 60 (*n* = 85, 57.8 %)¸ patients aged 1--10 year-old almost exclusively yielded *M. avium* and *M. intracellulare* (11 out of 12, 91.7 % in total), the most commonly encountered species in mycobacterial lymphadenitis in children \[[@CR12]\]. Of the 147 NTM clinical strains, 112 (76.2 %) were isolated from respiratory tract specimens (sputum and bronchoalveolar lavage), 4 (2.7 %) from blood, 16 (10.9 %) from lymph nodes, and the remaining 15 isolates (10.2 %) from other specimens, including urine, stool, skin, gastric lavage and other body fluid. In particular, all the blood specimens yielded *M. avium*, which was also the prevalent species isolated from adenitis episodes; *M. xenopi* and *M. kansasii* were isolated only from pulmonary specimens; *M. marinum* was isolated exclusively from skin samples. These results reflect the ability of the mycobacterial species to infect and localize in different body sites \[[@CR3]\].Table 1Species, patients' age and site of infection of NTM isolated at the Clinical Mycobacteriology Laboratory of Pisa University Hospital during years 2004--2014NTM speciesNo. of isolates (% of total isolates)No. of isolates (% of species isolates)Patient age rangeSite of isolation1--1011--2021--3031--4041--5051--6061--7071--80\>80Respiratory tractBloodLymph nodeOther^a^*M. avium*61 (41.5)8 (13.1)2 (3.3)1 (1.6)--8 (13.1)7 (11.5)9 (14.8)20 (32.8)6 (9.8)40 (65.6)4 (6.6)11 (18.0)6 (9.8)*M. intracellulare*21 (14.3)3 (14.3)----2 (9.5)--2 (9.5)5 (23.8)6 (28.6)3 (14.3)17 (81.0)--4 (19.0)--*M. gordonae*17 (11.6)------3 (17.6)4 (23.5)2 (11.8)3 (17.6)4 (23.5)1 (5.9)14 (82.4)----3 (17.6)*M. xenopi*14 (9.5)------5 (35.7)2 (14.3)2 (14.3)4 (28.6)--1 (7.1)14 (100.0)------*M. fortuitum*10 (6.8)--------1 (10.0)2 (20.0)3 (30.0)4 (40.0)--7 (70.0)----3 (30.0)*M. kansasii*7 (4.8)----1 (14.3)----1 (14.3)4 (57.1)1 (14.3)--7 (100.0)------*M. celatum*3 (2.0)1 (33.3)----------1 (33.3)1 (33.3)--2 (66.6)--1 (33.3)--*M. abscessus*2 (1.4)--------------1 (50.0)1 (50.0)1 (50.0)----1 (50.0)*M. chelonae*2 (1.4)------1 (50.0)1 (50.0)--------2 (100.0)------*M. marinum*2 (1.4)--------2 (100.0)--------------2 (100.0)*M. lentiflavum*2 (1.4)------------2 (100.0)----2 (100.0)------*M. simiae*2 (1.4)----------1 (50.0)--1 (50.0)--2 (100.0)------*M. scrofulaceum*1 (0.7)----------------1 (100.0)--1 (100.0)------*M. triplex*1 (0.7)----------------1 (100.0)1 (100.0)------*M. phocaicum*1 (0.7)----------------1 (100.0)1 (100.0)------*M. bolletii*1 (0.7)--------------1 (100.0)--1 (100.0)------Total147 (100.0)12 (8.2)2 (1.4)2 (1.4)11 (7.5)18 (12.2)17 (11.6)31 (21.1)40 (27.2)14 (9.5)112 (76.2)4 (2.7)16 (10.9)15 (10.2)^a^include isolates from urine, stool, skin, gastric lavage and other body fluids

The distribution over time of the NTM isolates is reported in Fig. [1](#Fig1){ref-type="fig"}. As shown, the number of NTM isolates increased considerably from five isolates in 2004 to 29 in 2014; a sharp increase occurred in the last 3 years. In 2014, in particular, *M. avium* and *M. intracellulare* were the prevalent isolates representing 58.6 % of total NTM isolates; the increase in MAC isolates occurred mostly in people aged over 60 with pulmonary infections, as also reported by others \[[@CR9], [@CR13], [@CR14]\]. Notably, *M. kansasii*, a pulmonary pathogen not reported before 2012 in our setting, was repeatedly isolated in the last 3 years, representing 9.6 % of total NTM isolates; *M. gordonae*, which is considered a non-pathogenic enviromental contaminant, was the third most frequently isolated species.Fig. 1NTM isolated at the Clinical Mycobacteriology Laboratory of Pisa University Hospital during years 2004--2014. Only the six prevalent species, out of the 16 isolated during the survey period, are individually reported with different column fillings; the other NTM species (*M. celatum, M. abscessus, M. chelonae, M. marinum, M. lentiflavum, M. simiae, M. scrofulaceum, M. triplex, M. phocaicum* and *M. bolletii*) are grouped together (see figure legend at the right side)

On the whole, the increase in isolation rate of NTM in our setting in recent years is in keeping with several reports all over the world \[[@CR7]--[@CR9], [@CR11], [@CR15]--[@CR19]\]. However, it is worthy to note that the distribution of the species of NTM isolated from clinical specimens differs markedly by geographic region. Table [2](#Tab2){ref-type="table"} summarizes a selection of the recent literature reporting NTM isolation rates in different settings and geographic regions. In Europe, *M. avium* and *M. intracellulare* were the most common species, reaching prevalence rates approximately as high as 40--60 % in Italy, United Kingdom and the Netherlands. Interestingly, in the United Kingdom, although *M. avium-intracellulare*, *M. malmoense* and *M. kansasii* were the prevalent species, the rise in NTM isolates was mostly due to *M. gordonae* generally isolated from pulmonary specimens in patients over 60 year-old \[[@CR9], [@CR13]\]; similarly, in a study from Croatia, the highest increase in NTM isolation frequency was attributed to *M. gordonae* and *M. fortuitum* \[[@CR11]\]; also studies from the Netherlands and Athens (Greece) showed high rates of *M. gordonae* isolates \[[@CR14], [@CR20]\]. In the United States the prevalent NTM species were *M. avium* complex, *M. gordonae* and *M. abscessus* \[[@CR21], [@CR22]\], while in Eastern Asia the most frequent were *M. avium* complex, *M. kansasii* and *M. abscessus* and *M. fortuitum* \[[@CR23]--[@CR25]\].Table 2Recent studies on isolation rates of NTM from human clinical specimens in different settingsSettingYearsPrevalent NTM species% of total isolatesTrendReferenceTuscany (Italy)2004--2014*M. avium*41.5IncreaseThis study*M. intracellulare*14.3*M. gordonae*11.6England, Wales and Northern Ireland1995--2006*M. avium-intracellulare*42.9Increase9*M. malmoense*13.7*M. kansasii*12.5Scotland2000--2010*M. avium* complex48.1No clear trend13*M. malmoense*17.7*M. abscessus*9.8The Netherlands2000--2006*M. avium* complex39.0Increase14*M. gordonae*14.1*M. kansasii*7.4Croatia2006--2010*M. gordonae*42.9Increase11*M. xenopi*15.5*M. fortuitum*11.5Athens (Greece)2007--2013*M. gordonae*13.9No trend20*M. avium*13.1*M. fortuitum*12.2Virginia (USA)2001--2009*M. avium* complex40.9Increase22*M. gordonae*28.7*M. abscessus*4.5Oregon (USA)2007--2012*M. avium-intracellulare*86Increase21*M. chelonae/abscessus*6Shangai (China)2008--2012*M. kansasii*45.0Increase23*M. intracellulare*20.8*M. chelonae/abscessus*14.9Cheonan (Korea)2005--2011*M. intracellulare*51.3Increase24*M. avium*14.7*M. kansasii*7.8South Korea2001--2011*M. avium* complex53Increase25*M. abscessus-massiliense*25*M. fortuitum*6

Conclusions {#Sec5}
===========

In conclusion, the present study, although not representing a population-based investigation, shows an increase in NTM isolation rate in our setting, which is consistent with the increasing rates seen elsewhere, and provides a snapshot of the prevalent NTM species in our setting. The clinical significance of the increased isolation rate of NTM from human specimens observed in the present study remains largely unknown for the difficulties to interpret whether the NTM isolations are related to colonisation or disease. Further studies involving detailed clinical data are needed to better understand the changes in NTM epidemiology.
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